Pastor JC. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 1998;43:3–18.

Article  CAS  PubMed  Google Scholar 

Hilton G, Machemer R, Michels R, Okun E, Schepens C, Schwartz A. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121–5.

Article  Google Scholar 

Pastor J. Pathogenesis, histopathology, and classification of PVR. In: Retinal detachment surgery and proliferative vitreoretinopathy: from scleral buckling to small-gauge vitrectomy. Cham: Springer; 2023. p. 189–202.

Stryjewski TP, Andreoli CM, Eliott D. Retinal detachment after open globe injury. Ophthalmology. 2014;121:327–33.

Article  PubMed  Google Scholar 

Han L, Jia J, Fan Y, Yang L, Yue Z, Zhang W, et al. The Vitrectomy Timing Individualization System for Ocular Trauma (VTISOT). Sci Rep. 2019;9:12612.

Article  PubMed  PubMed Central  Google Scholar 

Gensheimer WG, Kerber MT, Blanch RJ. The epidemiology and outcomes of combat ocular trauma among local nationals managed at a deployed military hospital in Afghanistan. Eye. 2021;35:2155–63.

Article  PubMed  PubMed Central  Google Scholar 

Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retinal Eye Res. 1998;17:77–98.

Article  CAS  Google Scholar 

Pastor JC, de la Rúa ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retinal Eye Res. 2002;21:127–44.

Article  Google Scholar 

Mudhar HS. A brief review of the histopathology of proliferative vitreoretinopathy (PVR). Eye. 2020;34:246–50.

Article  PubMed  Google Scholar 

Wu F, Eliott D. Molecular targets for proliferative vitreoretinopathy. Semin Ophthalmol. 2021;36:218–23.

Chaudhary R, Dretzke J, Scott R, Logan A, Blanch R. Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol. Syst Rev. 2016;5:1–5.

Article  Google Scholar 

Machemer R, m, Aaberg T, Freeman HM, Alexander RI, John SL, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159–65.

Article  CAS  PubMed  Google Scholar 

Di Lauro S, Kadhim MR, Charteris DG, Pastor JC. Classifications for Proliferative Vitreoretinopathy (PVR): an analysis of their use in publications over the last 15 years. J Ophthalmol. 2016;2016:7807596.

Article  PubMed  PubMed Central  Google Scholar 

Chaudhary R, Scott RAH, Wallace G, Berry M, Logan A, Blanch RJ. Inflammatory and fibrogenic factors in proliferative vitreoretinopathy development. Transl Vis Sci Technol. 2020;9:23.

Article  PubMed  PubMed Central  Google Scholar 

Yang S, Li H, Li M, Wang F. Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Discov Med. 2015;20:207–17.

PubMed  Google Scholar 

Ricker LJ, Kijlstra A, Kessels AG, De Jager W, Liem AT, Hendrikse F, et al. Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS ONE. 2011;6:e19141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakao S, Arima M, Ishikawa K, Kohno R, Kawahara S, Miyazaki M, et al. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Investig Ophthalmol Vis Sci. 2012;53:4323–8.

Article  CAS  Google Scholar 

Elfenbein A, Simons M. Syndecan-4 signaling at a glance. J Cell Sci. 2013;126:3799–804.

CAS  PubMed  PubMed Central  Google Scholar 

Quiroz-Reyes MA, Quiroz-Gonzalez EA, Quiroz-Gonzalez MA, Lima-Gomez V. Early versus delayed vitrectomy for open globe injuries: a systematic review and meta-analysis. Clin Ophthalmol. 2024;18:1889–1900.

Article  PubMed  PubMed Central  Google Scholar 

Kuhn F, Schrader W. Prophylactic chorioretinectomy for eye injuries with high proliferative-vitreoretinopathy risk. Clin Anat. 2018;31:28–38.

Article  PubMed  Google Scholar 

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.

Article  PubMed  PubMed Central  Google Scholar 

Glanville J, Kotas E, Featherstone R, Dooley G. Which are the most sensitive search filters to identify randomized controlled trials in MEDLINE? J Med Libr Assoc. 2020;108:556–63.

Article  PubMed  PubMed Central  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

Article  PubMed  Google Scholar 

Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology. 2008;115:1938–43.

Article  PubMed  Google Scholar 

Ahmadieh H, Nourinia R, Ragati Haghi A, Ramezani A, Entezari M, Rahmani G, et al. Oral colchicine for prevention of proliferative vitreoretinopathy: a randomized clinical trial. Acta Ophthalmol. 2015;93:e171–2.

Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology. 2001;108:1179–83.

Article  CAS  PubMed  Google Scholar 

Banerjee PJ, Quartilho A, Bunce C, Xing W, Zvobgo TM, Harris N, et al. Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective, randomized controlled clinical trial. Ophthalmology. 2017;124:757–67.

Article  PubMed  Google Scholar 

Banerjee PJ, Xing W, Bunce C, Woodcock M, Chandra A, Scott RA, et al. Triamcinolone during pars plana vitrectomy for open globe trauma: a pilot randomised controlled clinical trial. Br J Ophthalmol. 2016;100:949–55.

Article  PubMed  Google Scholar 

Binder S, Bonnet M, Velikay M, Gerard JP, Stolba U, Wedrich A, et al. Radiation therapy in proliferative vitreoretinopathy: a prospective randomized study. Graefe’s Arch Clin Exp Ophthalmol. 1994;232:211–4.

Article  CAS  Google Scholar 

Casswell EJ, Cro S, Cornelius VR, Banerjee PJ, Zvobgo TM, Edwards RT, et al. Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: the ASCOT study. Br J Ophthalmol. 2024;108:440–8.

Article  PubMed  Google Scholar 

Chang Y-C, Hu D-N, Wu W-C. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy. Am J Ophthalmol. 2008;146:440–446.e441.

Article  CAS  PubMed  Google Scholar 

Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C, et al. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology. 2004;111:2240–5.

Article  PubMed  Google Scholar 

Dehghan MH, Ahmadieh H, Soheilian M, Azarmina M, Moradian S, Ramezani AR, et al. Effect of oral prednisolone on visual outcomes and complications after scleral buckling. Eur J Ophthalmol. 2010;20:419–23.

Article  PubMed  Google Scholar 

Ganekal S, Dorairaj S. Effect of intraoperative 5-fluorouracil and low molecular weight heparin on the outcome of high-risk proliferative vitreoretinopathy. Saudi J Ophthalmol. 2014;28:257–61.

Article  PubMed  PubMed Central  Google Scholar 

Guo H, Yu J, He T, Chen S, Sun Z, Zhang J, et al. Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial. Br J Ophthalmol. 2024;108:1161–7.

Article  PubMed  Google Scholar 

Koerner F, Koerner-Stiefbold U, Garweg JG. Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial. Graefe’s Arch Clin Exp Ophthalmol. 2012;250:981–7.